FDA Grants Accelerated Approval to AstraZeneca’s New Breast Cancer Treatment
On Sept. 4, 2026, the U.S. Food and Drug Administration (FDA) announced they have expanded treatment options for…
On Sept. 4, 2026, the U.S. Food and Drug Administration (FDA) announced they have expanded treatment options for…
On Jul. 30, 2026, a study led by Cedars-Sinai Health Sciences University investigators found that women who test…
On May 13, 2026, DNA recovered from Neanderthal teeth found in Stajnia Cave in southern Poland shows the…
On Apr. 14, 2026, researchers from the Wellcome Sanger Institute, Cambridge University Hospitals NHS Foundation Trust (CUH), the…
On Mar. 10, 2025, Beam Therapeutics announced initial safety and efficacy data from its Phase 1/2 trial of…
On Sept. 26. 2024, a team of scientists led by Prof. Patrik Verstreken at the VIB-KU Leuven Center…
On Aug. 6, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved vorasidenib (Voranigo, Servier…
On Jun. 1, 2023, Illumina announced the new PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts with unprecedented…
On Apr. 26, 2023, Vertex announced the Food and Drug Administration (FDA) had approved the expanded use of…
On Apr. 25, 2023, the U.S. U.S. Food and Drug Administration (FDA announced it had approved Qalsody (tofersen) to…
On Mar. 7, 2023, researchers at the National Institutes of Health reported the benefits of screening adult patients…
On Nov. 3, 2022, researchers have identified the specific mutations in the mpox virus that contribute to its…
On Sept. 15, 2022, the National Institutes of Health (NIH) announced that a research team funded by the…
On Aug. 12, 2022, a group of global experts convened by WHO agreed on new names for monkeypox…
On May 3, 2021, University of British Columbia (UBC) researchers were the first in the world to publish…
On Mar. 16, 2021, Roche announced the launch of the cobas SARS-CoV-2 Variant Set 1 Test to detect…
On Mar. 9, 2021, PerkinElmer announced the launch of the PerkinElmer COVID-19 Antigen Test for the qualitative detection…
On Sept. 7, 2020, research from the Children’s Medical Center Research Institute at UT Southwestern (CRI) determined how…
On Aug. 12, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to NS Pharma’s Viltepso…
On Jun. 17, 2020, Howard Hughes Medical Institute (HHMI) investigators reported they had identified long-concealed hidden mutations within…